Bariatric surgery provides ‘huge’ reduction in major adverse liver outcomes, CV events

Bariatric surgery provides ‘huge’ reduction in major adverse liver outcomes, CV events

Adults with nonalcoholic steatohepatitis and obesity have a much lower risk for a major adverse liver outcome or major adverse cardiovascular event if they undergo bariatric surgery vs. nonsurgical treatment, according to study data.In findings published in JAMA, a group of adults with NASH and obesity who underwent bariatric surgery had an 88% lower risk for major adverse liver outcomes and a 70% reduced risk for a major CV event compared with a matched control group, in addition to significantly greater reductions in body weight and HbA1c.“There were dual benefits of weight loss,”Read More

Share on facebook
Share on twitter
Share on linkedin